FindTrial
Sign In

Treatment of non-responsive breast pain.

Complete oestrogen blockade in recalcitrant mastalgia: A pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/12/010745
Enrollment
10
Registered
2017-12-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Recalcitrant mastalgia

Interventions

Intervention1: Injection Goserelin 3.6mg depot i: Injection Goserelin 3.6mg depot injection subcutaneously with tablet centchroman 30mg OD for 03 months were given

Sponsors

Intra mural research grant
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: woman recalcitrant mastalgia with VAS than or equal to 7 on breast pain chart, no personal history of breast or ovarian cancer

Exclusion criteria

Exclusion criteria: Cancer breast Woman desiring pregnancy Woman with PCOD or cervical hyperplasia Pregnant or lactating woman Women not giving consent

Design outcomes

Primary

MeasureTime frame
Reduction in VAS score to less than or equal to 03 on the Breast pain chartTimepoint: Three months follow up after completion of treatment—

Secondary

MeasureTime frame
To note the decrease in pain score on Breast pain chartTimepoint: Three months follow up after completion of treatment—

Countries

India

Contacts

Public ContactSuhani

All India Institute of Medical Sciences, New Delhi

drsuhani@gmail.com9810534358

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026